retatrutide clinical trial obesity trials Retatrutide approval: FDA status, clinical results, and when it could be available New GLP-1 obesity drug, retatrutide,

The accelerated weight loss these medications provide can leave behind loose, sagging skin that exercise alone cannot address

What Happens When You Eat Too Little on GLP-1

Support & Care Breakdown Live Chat Human/AI The in-portal chat uses AI to handle basic questions and routes you to a human agent when it cant answer

Moderation matters more than usual

NEW - Blue Shield will launch three PPO Savings Plans offering expanded weight loss drug coverage in 2027: Full PPO Savings Embedded Deductible 3400 100% with Enhanced+ Rx Full PPO Savings Two-Tier Embedded Deductible 1700/3400/3400 90/60 with Enhanced+ Rx NOTE: Weight loss drugs under these plans are covered with prior authorization for BMI 30 or 27 with certain weight-related conditions, lowering the requirement from the previous BMI of 40

If hydration is hard, see electrolyte supplements while using GLP-1 medications